{"id":"W2293202443","doi":"10.1016/j.eururo.2016.02.030","title":"Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Solifenacin; Medicine; Mirabegron; Overactive bladder; Urology; Tolterodine; Urinary urgency","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001657599,0.0003848698,0.0007112714,0.0006494721,0.00008582329,0.00002183062,0.0001961776,0.00007134338,0.0001427266],"category_scores_gemma":[0.0003420906,0.0002446969,0.00005400728,0.0003339331,0.0001286824,0.0001516783,0.0001158215,0.0003349587,0.0000626711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007581784,"about_ca_system_score_gemma":0.0001461292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008492172,"about_ca_topic_score_gemma":0.00009129567,"domain_scores_codex":[0.9945053,0.002975762,0.0006737986,0.0007796015,0.0004473974,0.0006180734],"domain_scores_gemma":[0.9974594,0.001060803,0.0001665772,0.0005746968,0.000231556,0.0005070145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.912305,0.009901506,0.01004862,0.000009641216,0.000292932,0.0005290903,0.0140058,0.0000353132,0.008633033,0.000002453052,0.00007570734,0.0441609],"study_design_scores_gemma":[0.6053461,0.08414785,0.3058228,0.00007491816,0.00005788842,0.00001225828,0.0003563551,0.00001833662,0.002309704,0.000003177196,0.001571263,0.0002794097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900509,0.00004173203,0.00009433173,0.002223199,0.00005350614,0.006996138,0.00005176741,0.00003630097,0.0004521604],"genre_scores_gemma":[0.9981983,0.00005013286,0.00008650361,0.001188987,0.0001030133,0.00009500097,0.00002224468,0.00009799583,0.0001578552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3069589,"threshold_uncertainty_score":0.9978449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04777834130636659,"score_gpt":0.3576508429871424,"score_spread":0.3098725016807758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}